Traditionally, drug discovery has focused on tiny agents, but peptide alliances are increasingly gaining traction. This innovative approach embraces combining short amino acid chains with complementary therapeutic modalities to tackle complex illness pathways. By employing the specific characteristics of peptides – such as high selectivity and ab